Abel Hall LLC’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$153K Sell
11,304
-1,036
-8% -$16.7K 0.03% 741
2026
Q2
$253K Buy
12,340
+73
+0.6% +$1.67K 0.04% 585
2026
Q1
$270K Buy
12,267
+1,369
+13% +$23.8K 0.06% 463
2025
Q4
$128K Buy
+10,898
New +$140K 0.03% 590

Other funds holding CC

Abel Hall LLC's CC Position: Q3 2026 in Review

Abel Hall LLC reduced its Chemours (CC) stake by 8.4% in Q3 2026, selling an estimated $16.7K and leaving 11,304 shares worth $153K. The position accounts for 0.03% of the portfolio, ranked #741.

Abel Hall LLC first reported a position in CC in Q4 2025 and has held it in 4 quarters since. The position peaked at $270K in Q1 2026. 143 funds tracked by Wall St. Rank hold CC as of Q3 2026.

  • Abel Hall LLC held 11,304 shares of Chemours worth $153K as of Q3 2026.
  • Abel Hall LLC sold 1,036 Chemours shares in Q3 2026, an estimated $16.7K.
  • Chemours made up 0.03% of Abel Hall LLC's portfolio in Q3 2026, its #741 holding.
  • Abel Hall LLC first reported a position in Chemours in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Chemours position peaked at $270K in Q1 2026.
  • 143 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.